Krebs Biochemicals & Industries Ltd. - Outcome of Board Meeting

| Updated on May 20, 2019 Published on May 20, 2019

we herewith intimate the Exchange that the Board of Directors at their meeting held on 20th May, 2019 has considered and approved interalia the following:

a) Audited Financial results and the Auditors Report for the quarter and year ended 31st March, 2019. (Enclosed herewith).

b) Appointment of M/s Bhavani & Co., Chartered Accountants (Firm Registration No. 012139S) as Statutory Auditors of the Company subject to approval by the Shareholders of the Company in place of M/s Pavuluri & Co., who retires at the ensuing Annual General Meeting as per the provisions of Section 139 Companies Act, 2013.

c) The amended code of code of practices and procedures of fair disclosure of Unpublished Price Sensitive Information under Regulation 8(1), Chapter IV of SEBI (Prohibition of Insider Trading) Regulations, 2015, which has been amended to incorporate additional clauses mandated by the SEBI (Prohibition of Insider Trading) Amendment Regulations, 2018. (Enclosed herewith)

Kindly note that the meeting commenced at 13:32 PM, adjourned at 14:30PM, resumed at 15:50PM and concluded at 18:10 PM

This is for the information and records of the Exchange, Please.

Pdf Link: Krebs Biochemicals & Industries Ltd. - Outcome of Board Meeting

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on May 20, 2019
This article is closed for comments.
Please Email the Editor